We look at constraints posed by a developing nation context- infrastructure, skilled resources and affordable pricing as an opportunity to innovate.
We bring to market very high quality products that are reliable and extremely simple to use.
Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 23, 2023 | Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval | World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ -- Remidio has received CE mark approval for its Medios AI, to det... |
| Jan 15, 2016 | Med-tech startup Remidio raises Series B funding | Bangalore-based Remidio Innovative Solutions Pvt Ltd has raised an undisclosed amount in Series B funding from domestic HNIs and Cipher-Plexus Capital Advisors. The latter was also the investment banker for this transaction. Remidio, a heal... |
| Remidio Innovative Solutions | “We make eye care simple.” |
Reviews 0
FAQ about Remidio
When was Remidio founded?
Remidio was founded in 2009.
What has the press written about Remidio?
Parsers VC has collected 4 articles mentioning Remidio, among them “Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval” (Feb 23, 2023) and “Med-tech startup Remidio raises Series B funding” (Jan 15, 2016).
Is Remidio still active?
Yes, Remidio is active; its latest activity on Parsers VC dates from Jul 17, 2024.